Table 5.

- Correlation between epilepsy medications polypharmacy and adherence status.

Variables	Total		Adherence		Nonadherence		P-value
	Number	%≥	Number	(%)	Number	(%)
Polypharmacy
yes polypharmacy	60	29.27	49	(29.34)	11	(28.95)	0.962
No polypharmacy	145	70.73	118	(70.66)	27	(71.05)
Levetiracetam
Yes	115	55.56	90	(53.25)	25	(65.79)	0.160
No	92	44.44	79	(46.75)	13	(34.21)
Valproic Acid
Yes	21	10.14	17	(10.06)	4	(10.53)	0.931
No	186	89.86	152	(89.94)	34	(89.47)
Carbamazepine
Yes	58	28.02	46	(27.22)	12	(31.58)	0.589
No	149	71.98	123	(72.78)	26	(68.42)
Lamotrigine
Yes	24	11.59	23	(13.61)	1	(2.63)	0.040*
No	183	88.41	146	(86.39)	37	(97.37)
Phenytoin
Yes	4	1.93	4	(2.37)	0	(0.00)	0.441
No	203	98.07	165	(97.63)	38	(100.00)
Topiramate
Yes	5	2.42	3	(1.78)	2	(5.26)	0.228
No	202	97.58	166	(98.22)	36	(94.74)
Clonazepam
Yes	1	0.48	1	(0.59)	0	(0.00)	0.816
No	206	99.52	168	(99.41)	38	(100.00)
Lacosamide
Yes	5	2.42	5	(2.96)	0	(0.00)	0.359
No	202	97.58	164	(97.04)	38	(100.00)
Phenobarbital
Yes	1	0.48	1	(0.59)	0	(0.00)	0.816
No	206	99.52	168	(99.41)	38	(100.00)

Significant p-value